SciClone Pharmaceuticals Inc - Company & Market Research Reports

SciClone Pharmaceuticals is a specialty pharmaceutical company that provides therapies for oncology, infectious diseases, and cardiovascular disorders in the People's Republic of China, the United States, and Hong Kong. Its lead product is ZADAXIN, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers. Its best known products include DC Bead, Holoxan, Mesna, Endoxan, Methotrexate and more. It was founded in 1989 and is headquartered in Foster City, California.

2018 Atrial Fibrillation Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Atrial Fibrillation Drug Development- Pipeline Analysis Report

  • Report
  • 70 Pages
From
Sepsis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sepsis Therapeutics - Global Strategic Business Report

  • Report
  • 137 Pages
From
Hepatitis C Virus and Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Hepatitis C Virus and Therapeutics - Global Strategic Business Report

  • Report
  • 466 Pages
From
Sepsis - Pipeline Review, H2 2018 - Product Thumbnail Image

Sepsis - Pipeline Review, H2 2018

  • Report
  • 278 Pages
From
2018 Oral Mucositis Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Oral Mucositis Drug Development- Pipeline Analysis Report

  • Report
  • 70 Pages
From
Oral Thin Films Market, 2015 - 2025 - Product Thumbnail Image

Oral Thin Films Market, 2015 - 2025

  • Report
  • 249 Pages
From
Depression: Market Intelligence Review and Insights - Product Thumbnail Image

Depression: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Antivirals - Global Strategic Business Report - Product Thumbnail Image

Antivirals - Global Strategic Business Report

  • Report
  • 699 Pages
From
Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026  - Product Thumbnail Image

Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026

  • Report
  • 266 Pages
From
Competitor Analysis: Anti-Infective Peptides - Product Thumbnail Image

Competitor Analysis: Anti-Infective Peptides

  • Report
  • 68 Pages
From
Cystic Fibrosis: Pipeline Assessment and Insights - Product Thumbnail Image

Cystic Fibrosis: Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Epilepsy: Epidemiology Overview and Insights - Product Thumbnail Image

Epilepsy: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Global Peptide Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Peptide Therapeutics Market 2016-2020

  • Report
  • 81 Pages
From
Non-Small Cell Lung Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018

  • Report
  • 3034 Pages
From
Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2017-2021 - Product Thumbnail Image

Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2017-2021

  • Report
  • 77 Pages
From
Pancreatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Pancreatic Cancer Drugs - Global Strategic Business Report

  • Report
  • 405 Pages
From
Mucositis - Pipeline Review, H1 2014 - Product Thumbnail Image

Mucositis - Pipeline Review, H1 2014

  • Report
  • 46 Pages
From
Q4 2016 Earnings Call - SciClone Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q4 2016 Earnings Call - SciClone Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Q4 2016 Earnings Call - SciClone Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q4 2016 Earnings Call - SciClone Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Q3 2016 Earnings Call - SciClone Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q3 2016 Earnings Call - SciClone Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Loading Indicator
adroll